Is Jazz Pharmaceuticals PLC (JAZZ) Stock at the Top of the Biotechnology Industry?

Jazz Pharmaceuticals PLC (JAZZ) is around the top of the Biotechnology industry according to InvestorsObserver. JAZZ received an overall rating of 62, which means that it scores higher than 62 percent of all stocks. Jazz Pharmaceuticals PLC also achieved a score of 88 in the Biotechnology industry, putting it above 88 percent of Biotechnology stocks. Biotechnology is ranked 64 out of the 148 industries.

JAZZ has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on JAZZ!

See Full JAZZ Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 62 would rank higher than 62 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Jazz Pharmaceuticals PLC Stock Today?

Jazz Pharmaceuticals PLC (JAZZ) stock is trading at $159.71 as of 11:14 AM on Wednesday, Apr 6, a loss of -$3.17, or -1.95% from the previous closing price of $162.88. The stock has traded between $156.17 and $160.59 so far today. Volume today is low. So far 270,037 shares have traded compared to average volume of 603,866 shares. Click Here to get the full Stock Report for Jazz Pharmaceuticals PLC stock.